Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

YM150 Phase III Study - An Open-label, Multi-center Study in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities

NCT00937911 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00937911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00937911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
YM150 Phase III Study - An Open-label, Multi-center Study in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities
Lead sponsor
Astellas Pharma Inc
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2009
Completion date
April 30, 2010
Enrollment
101 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism